NEUROMYELITIS OPTICA SPECTRUM DISORDERS
Clinical trials for NEUROMYELITIS OPTICA SPECTRUM DISORDERS explained in plain language.
Never miss a new study
Get alerted when new NEUROMYELITIS OPTICA SPECTRUM DISORDERS trials appear
Sign up with your email to follow new studies for NEUROMYELITIS OPTICA SPECTRUM DISORDERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for NMOSD: drug aims to slash relapse rate in chinese patients
Disease control OngoingThis study tests whether eculizumab can reduce the number of relapses in Chinese adults with a rare autoimmune disease called NMOSD. Participants must have had at least one attack in the past year and test positive for a specific antibody. The drug is given alongside stable maint…
Matched conditions: NEUROMYELITIS OPTICA SPECTRUM DISORDERS
Phase: PHASE3 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 19, 2026 11:47 UTC
-
10,000 brains mapped: new charts could spot Alzheimer's and MS earlier
Diagnosis ENROLLING_BY_INVITATIONThis study aims to create detailed brain charts for the Chinese population by collecting MRI scans from over 10,000 healthy people of different ages. These charts will show what a normal brain looks like at each age, helping doctors detect diseases like multiple sclerosis, Alzhei…
Matched conditions: NEUROMYELITIS OPTICA SPECTRUM DISORDERS
Sponsor: Beijing Tiantan Hospital • Aim: Diagnosis
Last updated May 26, 2026 08:40 UTC